- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: cebranopadol.
Displaying page 1 of 1.
EudraCT Number: 2013-001877-26 | Sponsor Protocol Number: KF6005/09 | Start Date*: 2013-10-23 | |||||||||||
Sponsor Name:Grünenthal GmbH | |||||||||||||
Full Title: An open-label, multi-site trial to describe the safety and tolerability of oral cebranopadol administered for 26 weeks in subjects with cancer-related pain who have completed treatment in the KF600... | |||||||||||||
Medical condition: cancer-related pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) GB (Completed) BE (Completed) HU (Completed) SK (Completed) AT (Completed) DE (Completed) DK (Completed) PL (Completed) ES (Completed) BG (Completed) NL (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001316-35 | Sponsor Protocol Number: KF6005/07 | Start Date*: 2012-12-20 | |||||||||||
Sponsor Name:Grünenthal GmbH | |||||||||||||
Full Title: Efficacy, safety, and tolerability of oral Cebranopadol versus morphine sulphate PR in subjects with chronic moderate to severe pain related to cancer. | |||||||||||||
Medical condition: The trial population, comprising patients with cancer pain requiring WHO Step III analgesics, will represent the typical population suffering from cancer-related pain. Patient having various types ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) DE (Prematurely Ended) HU (Completed) SE (Completed) ES (Completed) SK (Completed) PL (Completed) NL (Completed) AT (Completed) DK (Completed) BG (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000473-68 | Sponsor Protocol Number: KF6005/08 | Start Date*: 2013-08-21 | |||||||||||
Sponsor Name:Grünenthal GmbH | |||||||||||||
Full Title: Efficacy, safety and tolerability of multiple doses of oral cebranopadol in subjects with moderate to severe chronic pain due to diabetic peripheral neuropathy | |||||||||||||
Medical condition: Moderate to severe chronic pain due to diabetic peripheral neuropathy (DPN) requiring analgesia in subjects with well-controlled and stable type 1 or type 2 diabetes mellitus. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) IT (Completed) NL (Completed) BE (Completed) ES (Completed) DE (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001920-36 | Sponsor Protocol Number: KF6005/06 | Start Date*: 2012-09-21 | |||||||||||
Sponsor Name:Grünenthal GmbH | |||||||||||||
Full Title: Efficacy, safety, and tolerability of GRT6005 in subjects with moderate to severe chronic low back pain | |||||||||||||
Medical condition: moderate to severe chronic low back pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) DE (Completed) BE (Completed) GB (Completed) ES (Completed) SE (Completed) DK (Completed) HU (Completed) FI (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.